Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
195K
-
Shares change
-
+103K
-
Total reported value, excl. options
-
$197K
-
Value change
-
+$108K
-
Number of buys
-
7
-
Number of sells
-
-4
-
Price
-
$1.01
Significant Holders of Allarity Therapeutics, Inc. - COM (ALLR) as of Q2 2025
12 filings reported holding ALLR - Allarity Therapeutics, Inc. - COM as of Q2 2025.
Allarity Therapeutics, Inc. - COM (ALLR) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 195K shares
.
Largest 10 shareholders include XTX Topco Ltd (51K shares), GEODE CAPITAL MANAGEMENT, LLC (50.7K shares), UBS Group AG (48K shares), JANE STREET GROUP, LLC (26.4K shares), Squarepoint Ops LLC (14.5K shares), Tower Research Capital LLC (TRC) (3.07K shares), CITIGROUP INC (1.47K shares), BANK OF AMERICA CORP /DE/ (138 shares), OSAIC HOLDINGS, INC. (7 shares), and CORSAIR CAPITAL MANAGEMENT, L.P. (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.